Literature DB >> 9016532

The human type I collagen mutation database.

R Dalgleish1.   

Abstract

Type I collagen is the most abundant and ubiquitously distributed of the collagen family of proteins. It is a heterotrimer comprising two alpha1(I) chains and one alpha2(I) chain which are encoded by the unlinked loci COL1A1 and COL1A2 respectively. Mutations at these loci result primarily in the connective tissue disorders osteogenesis imperfecta and Ehlers-Danlos syndrome types VIIA and VIIB. Two instances of osteoporosis and a single instance of Marfan syndrome are also the result of mutations at these loci. The mutation data are accessible on the world wide web at http://www.le.ac.uk/depts/ge/collagen/collagen.html

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9016532      PMCID: PMC146420          DOI: 10.1093/nar/25.1.181

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  20 in total

1.  Three new polymorphisms at the COL1A2 locus.

Authors:  D Strobel; T Tsuneyoshi; H Kuivaniemi; G Tromp; L D Spotila; C T Baldwin; C D Constantinou; A Ganguly; L Sereda; B P Sokolov
Journal:  Matrix       Date:  1992-04

2.  Completion of the last half of the structure of the human gene for the Pro alpha 1 (I) chain of type I procollagen (COL1A1).

Authors:  A Westerhausen; C D Constantinou; M Pack; M Z Peng; C Hanning; A S Olsen; D J Prockop
Journal:  Matrix       Date:  1991-12

Review 3.  The zipper-like folding of collagen triple helices and the effects of mutations that disrupt the zipper.

Authors:  J Engel; D J Prockop
Journal:  Annu Rev Biophys Biophys Chem       Date:  1991

4.  G to A polymorphism in exon 45 of the COL1A1 gene.

Authors:  B P Sokolov; C D Constantinou; T Tsuneyoshi; J P Zhuang; D J Prockop
Journal:  Nucleic Acids Res       Date:  1991-08-11       Impact factor: 16.971

Review 5.  Collagens: molecular biology, diseases, and potentials for therapy.

Authors:  D J Prockop; K I Kivirikko
Journal:  Annu Rev Biochem       Date:  1995       Impact factor: 23.643

Review 6.  The collagen superfamily.

Authors:  J C Brown; R Timpl
Journal:  Int Arch Allergy Immunol       Date:  1995-08       Impact factor: 2.749

7.  Internal deletion in a collagen gene in a perinatal lethal form of osteogenesis imperfecta.

Authors:  M L Chu; C J Williams; G Pepe; J L Hirsch; D J Prockop; F Ramirez
Journal:  Nature       Date:  1983 Jul 7-13       Impact factor: 49.962

Review 8.  Perinatal lethal osteogenesis imperfecta.

Authors:  W G Cole; R Dalgleish
Journal:  J Med Genet       Date:  1995-04       Impact factor: 6.318

9.  Genetic heterogeneity in osteogenesis imperfecta.

Authors:  D O Sillence; A Senn; D M Danks
Journal:  J Med Genet       Date:  1979-04       Impact factor: 6.318

10.  Osteogenesis imperfecta type III: mutations in the type I collagen structural genes, COL1A1 and COL1A2, are not necessarily responsible.

Authors:  G A Wallis; B Sykes; P H Byers; C G Mathew; D Viljoen; P Beighton
Journal:  J Med Genet       Date:  1993-06       Impact factor: 6.318

View more
  85 in total

Review 1.  Human genotype-phenotype databases: aims, challenges and opportunities.

Authors:  Anthony J Brookes; Peter N Robinson
Journal:  Nat Rev Genet       Date:  2015-11-10       Impact factor: 53.242

2.  CD and NMR investigation of collagen peptides mimicking a pathological Gly-Ser mutation and a natural interruption in a similar highly charged sequence context.

Authors:  Xiuxia Sun; Songqing Liu; Wenyuan Yu; Shaoru Wang; Jianxi Xiao
Journal:  Protein Sci       Date:  2015-11-26       Impact factor: 6.725

Review 3.  Genetic diseases of connective tissues: cellular and extracellular effects of ECM mutations.

Authors:  John F Bateman; Raymond P Boot-Handford; Shireen R Lamandé
Journal:  Nat Rev Genet       Date:  2009-03       Impact factor: 53.242

Review 4.  Materiomics: biological protein materials, from nano to macro.

Authors:  Steven Cranford; Markus J Buehler
Journal:  Nanotechnol Sci Appl       Date:  2010-11-12

5.  Single molecule effects of osteogenesis imperfecta mutations in tropocollagen protein domains.

Authors:  Alfonso Gautieri; Simone Vesentini; Alberto Redaelli; Markus J Buehler
Journal:  Protein Sci       Date:  2009-01       Impact factor: 6.725

6.  Dissecting the genetics of human high myopia: a molecular biologic approach.

Authors:  Terri L Young
Journal:  Trans Am Ophthalmol Soc       Date:  2004

7.  Complex heterozygous WNT1 mutation in severe recessive osteogenesis imperfecta of a Chinese patient.

Authors:  Yanqin Lu; Yunzhang Dai; Yanzhou Wang; Naixiang Zhai; Jian Zhang; Junlong Liu; Xiaoli Yin; Tianyou Li; Xiuzhi Ren; Jinxiang Han
Journal:  Intractable Rare Dis Res       Date:  2018-02

Review 8.  Consortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans.

Authors:  Joan C Marini; Antonella Forlino; Wayne A Cabral; Aileen M Barnes; James D San Antonio; Sarah Milgrom; James C Hyland; Jarmo Körkkö; Darwin J Prockop; Anne De Paepe; Paul Coucke; Sofie Symoens; Francis H Glorieux; Peter J Roughley; Alan M Lund; Kaija Kuurila-Svahn; Heini Hartikka; Daniel H Cohn; Deborah Krakow; Monica Mottes; Ulrike Schwarze; Diana Chen; Kathleen Yang; Christine Kuslich; James Troendle; Raymond Dalgleish; Peter H Byers
Journal:  Hum Mutat       Date:  2007-03       Impact factor: 4.878

9.  Genotype-phenotype correlations in nonlethal osteogenesis imperfecta caused by mutations in the helical domain of collagen type I.

Authors:  Frank Rauch; Liljana Lalic; Peter Roughley; Francis H Glorieux
Journal:  Eur J Hum Genet       Date:  2010-01-20       Impact factor: 4.246

10.  Differential response to intracellular stress in the skin from osteogenesis imperfecta Brtl mice with lethal and non lethal phenotype: a proteomic approach.

Authors:  Laura Bianchi; Assunta Gagliardi; Roberta Gioia; Roberta Besio; Chiara Tani; Claudia Landi; Maria Cipriano; Anna Gimigliano; Antonio Rossi; Joan C Marini; Antonella Forlino; Luca Bini
Journal:  J Proteomics       Date:  2012-02-18       Impact factor: 4.044

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.